Answer extracted from the B2B Vault: The Biz To Biz Podcast — listen to the full episode below.
What happens when merchants get placed on the Visa and MasterCard match list?
Once merchants are placed on the match list, the chances of obtaining credit card processing again are virtually zero, and they remain blocked for five years. Even after that period expires, payment processors can re-evaluate the original reasons for the listing, and if illegal products were involved, approval remains extremely unlikely because card networks have zero tolerance for illegal sales.
The Visa and MasterCard match list functions as a permanent enforcement mechanism within the payment industry. When a merchant lands on this list—typically due to violations involving illegal products, compliance failures, or fraudulent activity—the financial impact is devastating. Being named to the list means that major payment processors will refuse to open or renew merchant accounts, effectively cutting off the business from credit and debit card revenue streams.
The five-year tenure on the match list is not a soft restriction. As Angela Salter explains in the episode, after those five years elapse, a merchant seeking reinstatement faces additional scrutiny. Payment networks conduct historical reviews of the original violation to determine whether reactivation is warranted. This retrospective evaluation means the initial offense continues to weigh heavily on future applications.
The severity of the original infraction determines post-list prospects. Merchants selling illegal products face the steepest barrier to reinstatement. Because card brands maintain strict liability standards around illegal commerce, even a five-year cooling-off period offers no guarantee of forgiveness. Payment processors view such violations as reputational and legal liabilities that extend far beyond the incident itself.
"We certify based on current applicable laws and regulations, not what a committee thinks might be true in a year or two."
Angela Salter — Vice President of Enterprise Certification Sales and Partnerships at LegitScript. Salter oversees enterprise customer onboarding and account management for merchants seeking certification, as well as strategic partnerships with ad platforms and card brands that mandate LegitScript compliance for telemedicine and pharmacy operations. Her role focuses on ensuring merchants understand and meet the regulatory requirements set by Visa, MasterCard, and federal authorities before processing begins.
For merchants in high-risk industries like telemedicine and pharmaceutical sales, this episode provides critical compliance guidance to avoid ending up on the match list in the first place. Prevention through proper certification and transparent marketing is far more effective than attempting to rebuild after placement.
The long-term business consequences
Placement on the match list doesn't just mean a temporary loss of payment processing—it can signal the end of an online business model entirely. Without access to Visa and MasterCard processing, most e-commerce merchants cannot operate competitively. The reputational damage extends beyond the financial network, as processors communicate violations to industry databases and compliance platforms that other businesses rely on during due diligence.
Merchants who sold illegal products face the harshest outcome. Even if a business changes ownership or management, the match list history remains attached to the business identity. This permanence reflects the card networks' fundamental position: they will not knowingly facilitate commerce in illegal goods under any circumstances.
See also
How does LegitScript treat websites that claim products are research-only while marketing them for human consumption?
If a website labels a product as research use only on the bottle but the entire page discusses fat loss, recovery, anti-aging, or longevity, the label and marketing message are in direct conflict, triggering regulatory enforcement.
What enforcement actions have occurred against research-only peptide sellers?
Research-only peptide companies have faced significant penalties including fines ranging from $50,000 to $200,000, with some companies fined into the millions for misrepresenting and marketing products.
How did compounding pharmacies need to adapt after the GLP-1 shortage ended?
When the FDA shortage was deemed over, the FDA announced a specific timeframe for compounding pharmacies to cease GLP-1 operations, requiring rapid compliance and significant business model changes.
Key takeaways
- Match list placement results in a five-year ban from credit card processing with minimal chance of reinstatement.
- After five years, payment processors review the original violation before considering approval, with no guarantee of success.
- Merchants who sold illegal products face the harshest outcome, as card networks maintain zero tolerance for illegal commerce.
- The match list has lasting reputational consequences that extend beyond payment processing to broader business operations.